Some individuals who have successfully lost weight using injectable medications like Mounjaro and Wegovy are experiencing weight regain after switching to newer, oral versions of these drugs. Allie Hudson, 42, shared her experience after losing nearly 8 stone (approximately 112 pounds) on Mounjaro injections. She transitioned to oral weight-loss pills due to cost concerns but has since gained a significant amount of weight back.
"Since I started the pills, my weight just keeps going up and down, and nothing is moving," Hudson stated. "It's been two months now. I don't know why I'm not responding."
Hudson initially switched to the Wegovy injection, which costs £149 per month. Later, she opted for the newly approved Wegovy pill, hoping for a long-term solution. However, this switch led to her current struggles.
Experts suggest that the difference in effectiveness between the injectable and oral forms might be due to several factors. The concentration and delivery method of the active ingredients, such as semaglutide, can vary. Injectables deliver a consistent dose directly into the bloodstream, potentially leading to more sustained appetite suppression and weight loss. Oral medications, on the other hand, are absorbed through the digestive system, which can be less predictable.
Adherence to treatment is another critical factor. Some patients find it easier to consistently take a daily pill than to remember weekly or bi-weekly injections. Conversely, others may find managing a pill regimen more challenging, leading to missed doses and reduced efficacy. The psychological aspect of taking a pill versus an injection might also influence patient behavior and adherence. For some, the transition signifies a shift in their weight management journey, and renewed diligence may be required.